ROOT OF SKIN™ Skincare Line Sells Out at Product Launch on QVC Japan
Nov 28, 2018, 13:53 ET
IRVINE, Calif., Nov. 28, 2018 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that the Company's revolutionary stem-cell based ROOT OF SKIN™ skincare line sold out at launch on the Japanese home shopping channel QVC Japan. ROOT OF SKIN™ Revitalizing Face Renewal Serum and ROOT OF SKIN™ Revitalizing Eye Renewal Complex debuted on November 26, 2018 at 14:00 JST, selling out its complete stock to customers during only 45 minutes of the one-hour program. The occasion marked the first time a stem cell-based skincare product had been offered on QVC Japan, setting records for both product release and sales.
"QVC Japan is one of the biggest sales channels in one of the largest skincare markets in the world," said Christi Douglass, AIVITA's Marketing and Business Development Officer. "A sell-out launch is reassuring as we prepare to launch our professional line ROOT OF SKIN™ MD to physicians throughout Japan."
ROOT OF SKIN™ is AIVITA's proprietary skincare line for skin rejuvenation, made possible through the same proprietary knowledge and expertise used to develop its cutting-edge stem cell therapies. The all-new actives complex SourceCode Technology™ contains the complete set of factors and supporting biological components present in young, healthy skin.
"Not only has a revolutionary skin care product disrupted the marketplace," said Dr. Hans S. Keirstead, AIVITA's Chairman and CEO, "An AIVITA mission has been realized: 100% of the proceeds from ROOT OF SKIN™ sales are being used to treat women with ovarian cancer."
About ROOT OF SKIN™
ROOT OF SKIN™ is a rejuvenating line of skincare products fueled by an unrelenting pursuit for advancements in life-changing and life-saving treatments. Harnessing breakthroughs in stem cell therapy, AIVITA Biomedical developed a technology that does more than just boost regeneration. The patented actives complex SourceCode Technology™ renews, repairs and protects, just as your skin did at its youngest and healthiest stage. Rich with every biological component healthy skin needs for development, and free of any unnecessary ingredients. All proceeds support treatment of women with ovarian cancer.
About AIVITA Biomedical
AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its therapeutic pipeline and commercial line of skin care products.
SOURCE AIVITA Biomedical